Crowdfunding COVID-19 vaccine development
Axon Neuroscience is launching the world's first crowdfunding exercise for the development of a COVID-19 vaccine, following what it says are strong pre-clinical results for its candidate.
Archives for September 28, 2020
Novel nasal spray reduces viral replication by up to 96%: according to COVID-19 challenge study
Ena Respiratory’s preventative nasal spray treatment could reach human trials within four months, following results from an animal study released today which showed the spray reduced COVID-19 replication by up to 96%.